A Technology Ecosystem Grounded in Data Transformation
The Celéri proprietary platform was built with data gathering and governance as the sole focus. Gathering data in the form of patient reported outcomes and patient-level data for point-of-care live decision-making support, federating matching data elements for deeper case storytelling, leveraging data for clinical study RWE and ultimately curating downstream datasets (data lakes, science clouds, etc) for our own community and new specialties or diseases or products seeking a boutique partner. Today, we are so much more than a platform – we are an ecosystem.
Tech Platform
Our technology platform is the hub of our organization. The platform holds all of our products that support point of care data gathering, our rules engine for accurate patient engagement based on clinical path criteria, research inclusion/exclusion randomized patient mining, research data capture products, ML/AI, mobile applications, dataset building and much more.
Research Products
The Celéri Explorer Research Group of key partners and products provide an agile team plus a product set for researchers to quickly spin up projects that ensure study feasibility, fast study deployment, a proven EDC & data management system, high quality data, ease of participant management & engagement – and immediate visibility of results.
Ask us about our:
– Assurance of compliance from the start with built-in ISO 14155:2020, EU MDR, and FDA requirements. In addition, you’ll get 13 ready-to-use and customizable compliance document templates.
– Support for multi-indication studies.
– Easily make adjustments to your study designs according to different countries’ requirements and EC approvals.
– Support for dynamic visits, biometric data gathering and treatments.
– Simple 3-step study builder.
Mobile Products
Our mobile technology is at the height of development with so many projects in incubation. Let us build you a mobile app that engages with study patients or gathers PROs or supports care plan adherence activity or remotely monitors patients or supports gamification for deeper engagement or acts as a digital therapeutic – or one where our Research Group can walk through the FDA clearance process for software-as-a- medical device. The sky is the limit.